Headline News about Ucb S.A.![]() ![]()
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
August 29, 2024
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]()
UCB's Rare Childhood Epilepsy Drug Scores FDA Approval
March 28, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|